UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.47B |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$2.93B |
| 3 |
Vanguard Russell 1000 Value ETF
VONV
|
+$2.75B |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.69B |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$2.33B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.44B |
| 2 |
Micron Technology
MU
|
+$919M |
| 3 |
CYBR
CyberArk
CYBR
|
+$851M |
| 4 |
Honeywell
HON
|
+$606M |
| 5 |
Merck
MRK
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.16% |
| 2 | Technology | 16.96% |
| 3 | Financials | 8.4% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6301
Vivani Medical
VANI
$111M
| $338K | ﹤0.01% |
337,749
+331,035
| +4,931% | +$414K |
2014 Q4
45 quarters
|
|
|
NCZ
6302
Virtus Convertible & Income Fund II
NCZ
$266M
| $337K | ﹤0.01% |
25,162
-484
| -2% | -$6.92K |
2014 Q4
45 quarters
|
|
6303
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$182M
| $337K | ﹤0.01% |
3,732
-58
| -2% | -$5.57K |
2020 Q4
21 quarters
|
|
6304
BARK
BARK
$73.4M
| $337K | ﹤0.01% |
33,198
+26,305
| +382% | +$404K |
2021 Q2
19 quarters
|
|
6305
Invesco Dorsey Wright Energy Momentum ETF
PXI
$56.7M
| $336K | ﹤0.01% |
5,645
-3,163
| -36% | -$168K |
2014 Q4
45 quarters
|
|
6306
Neuraxis
NRXS
$89.3M
| $336K | ﹤0.01% |
45,342
-3,488
| -7% | -$19.1K |
2025 Q4
1 quarter
|
|
6307
Pacer Lunt Large Cap Alternator ETF
ALTL
$84.1M
| $335K | ﹤0.01% |
7,642
-42
| -0.5% | -$1.87K |
2021 Q2
19 quarters
|
|
|
FSSL
6308
FS Specialty Lending Fund
FSSL
$900M
| $332K | ﹤0.01% |
26,537
-26,097
| -50% | -$340K |
2025 Q4
1 quarter
|
|
6309
AiRWA Inc
YYAI
$4.72M
| $330K | ﹤0.01% |
494
+113
| +30% | +$97.5K |
2025 Q4
1 quarter
|
|
|
EFSI
6310
Eagle Financial Services Inc
EFSI
$246M
| $329K | ﹤0.01% |
9,399
-63,695
| -87% | -$2.36M |
2025 Q1
4 quarters
|
|
6311
Amplify Alternative Harvest ETF
MJ
$104M
| $328K | ﹤0.01% |
14,257
+185
| +1% | +$4.9K |
2024 Q4
5 quarters
|
|
6312
The RMR Group
RMR
$303M
| $327K | ﹤0.01% |
21,121
-9,213
| -30% | -$150K |
2015 Q4
41 quarters
|
|
6313
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$349M
| $326K | ﹤0.01% |
7,528
-210
| -3% | -$9.39K |
2014 Q4
45 quarters
|
|
6314
Syntec Optics
OPTX
$368M
| $326K | ﹤0.01% |
46,426
+7,618
| +20% | +$47K |
2024 Q1
8 quarters
|
|
6315
MIND Technology
MIND
$41M
| $326K | ﹤0.01% |
39,045
-1,997
| -5% | -$17.4K |
2020 Q1
24 quarters
|
|
|
VWAV
6316
VisionWave Holdings
VWAV
$10.6M
| $326K | ﹤0.01% |
3,435
+1,142
| +50% | +$204K |
2025 Q3
2 quarters
|
|
|
RJET
6317
Republic Airways Holdings
RJET
$826M
| $325K | ﹤0.01% |
18,200
+15,983
| +721% | +$298K |
2025 Q3
2 quarters
|
|
6318
Ponce Financial Group
PDLB
$492M
| $324K | ﹤0.01% |
19,401
+3,108
| +19% | +$51.2K |
2023 Q1
12 quarters
|
|
6319
Invesco S&P 500 Equal Weight Real Estate ETF
RSPR
$81.8M
| $324K | ﹤0.01% |
9,756
-3,514
| -26% | -$121K |
2021 Q2
19 quarters
|
|
|
CLDT
6320
Chatham Lodging
CLDT
$637M
| $323K | ﹤0.01% |
41,045
+29,799
| +265% | +$222K |
2014 Q4
45 quarters
|
|
|
HQL
6321
abrdn Life Sciences Investors
HQL
$538M
| $321K | ﹤0.01% |
19,758
+1,145
| +6% | +$19.1K |
2014 Q4
45 quarters
|
|
6322
Distillate US Fundamental Stability & Value ETF
DSTL
$2.01B
| $319K | ﹤0.01% |
5,503
-410
| -7% | -$24.6K |
2024 Q2
7 quarters
|
|
6323
TriSalus Life Sciences
TLSI
$266M
| $318K | ﹤0.01% |
79,552
+74,403
| +1,445% | +$364K |
2021 Q1
20 quarters
|
|
6324
Nuveen Core Plus Impact Fund
NPCT
$263M
| $318K | ﹤0.01% |
31,192
+3,674
| +13% | +$37.9K |
2021 Q2
19 quarters
|
|
|
AWP
6325
abrdn Global Premier Properties Fund
AWP
$314M
| $318K | ﹤0.01% |
28,762
-10,937
| -28% | -$129K |
2014 Q4
45 quarters
|
|
Similar funds
UBS Group's Q1 2026 Portfolio in Review
As of Q1 2026, UBS Group held 11,786 positions worth $666B, up 8% from $617B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $74.2B of net new capital in Q1 2026, opening 1,344 new positions and adding to 4,798 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UBS Group, an estimated $1.44B trimmed.
- UBS Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $4.47B increase.
- UBS Group's biggest Q1 2026 reduction was UBS Group, cutting an estimated $1.44B.
- UBS Group fully exited CyberArk in Q1 2026, selling an estimated $851M.
- UBS Group's ten largest holdings make up 13% of its $666B portfolio in Q1 2026.
- UBS Group opened 1,344 new positions and closed 1,383 in Q1 2026.
- UBS Group's portfolio value rose 8% quarter-over-quarter to $666B.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.